Cosmos Health Inc COSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
-
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
-
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
-
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
-
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
-
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
-
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
-
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
Trading Information
- Previous Close Price
- $0.32
- Day Range
- $0.31–0.34
- 52-Week Range
- $0.16–1.31
- Bid/Ask
- $0.32 / $0.32
- Shares Outstanding
- 100.63M
- Market Cap
- $32.30M
- Volume/Avg
- 3M / 5M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.19
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 163
- Website
- https://www.cosmoshealthinc.com
Valuation
|
Metric
|
COSM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.25 |
Price/Sales | 0.19 |
Price/Cash Flow | — |
Price/Earnings
COSM
Financial Strength
|
Metric
|
COSM
|
|---|---|
Quick Ratio | 0.68 |
Current Ratio | 1.05 |
Interest Coverage | −5.67 |
Quick Ratio
COSM
Profitability
|
Metric
|
COSM
|
|---|---|
Return on Assets (Normalized) | −11.13% |
Return on Equity (Normalized) | −32.96% |
Return on Invested Capital (Normalized) | −9.40% |
Return on Assets
COSM
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|TfvrQ% | LOCK|$?#b | $107B | |||
| Cencora Inc
COR
| LOCK|>tKwSK | LOCK|>snX> | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|&JV!%@# | LOCK|R&@& | $54B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|&l!X | $21B | |||
| Henry Schein Inc
HSIC
| LOCK|>!$R@G | LOCK|NtD^ | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|sG% | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|R% | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|$DW | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|rCQqW | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|?JR | $4B |
United States